Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Risk Factors of Developing Postinfectious Irritable Bowel Syndrome in Shigellosis Patients, 5 Years After Hospitalization During the Outbreak Publisher



Soheilipour M1 ; Chahichi A1 ; Mohajer H2 ; Ghomashi N3 ; Roohafza H4 ; Adibi P1
Authors
Show Affiliations
Authors Affiliations
  1. 1. Isfahan Gastroenterology and Hepatology Research Center, Isfahan University of Medical Sciences, Isfahan, Iran
  2. 2. Faculty of Medical School, Najafabad Branch, Islamic Azad University, Isfahan, Iran
  3. 3. School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran
  4. 4. Isfahan Cardiovascular Research Center, Isfahan University of Medical Sciences, Isfahan, Iran

Source: Open Forum Infectious Diseases Published:2024


Abstract

Background. Irritable bowel syndrome (IBS) can be triggered by bacterial dysentery. This study aimed to investigate postinfectious IBS and its risk factors after the shigellosis outbreak in hospitalized patients. Methods. This retrospective study was conducted in 2020-2021 in referral hospitals for Shigella gastroenteritis during the 2014 shigellosis outbreak in Isfahan. The Shigella-infected group included hospitalized shigellosis patients with clinical symptoms and positive stool culture. The control group included patients matched pairwise on age and sex to the Shigella-infected group, admitted to the same hospitals in the same period with diagnoses other than shigellosis. Both groups had no history of diagnosed IBS before the outbreak. The incidence of IBS (according to Rome-III criteria) and its related factors was compared between the 2 groups 5 years after infection. Results. Of 619 participants, 220 (35.5%) were in the Shigella-infected group. The 5-year incidence of IBS was 31.8% and 5.7% in the Shigella-infected and control groups, respectively. Multivariate analysis showed that shigellosis was significantly associated with increased risk of IBS (odds ratio [OR], 17.18 [95% confidence interval {CI}, 9.37-31.48]). Multivariate analysis indicated education level (OR, 4.15 [95% CI, 1.47-11.73]), diarrhea lasting >4 days (OR, 1.69 [95% CI, 1.17-2.44]), and abdominal cramps during the infection (OR, 0.27 [95% CI, .77-.95]) associated with postinfectious IBS (P < .05). Conclusions. Hospitalized patients with Shigella gastroenteritis are at increased risk of IBS within 5 years after infection. Factors such as higher education level and the absence of abdominal cramps and diarrhea persisting for >5 days during hospitalization can further increase this risk. © 2024 Oxford University Press. All rights reserved.
Related Docs
View other Related Docs
1. A Sustained Epidemic of Shigellosis in Isfahan Province, 2015, Journal of Kerman University of Medical Sciences (2018)
2. Prevalence of Shigellosis in Iranian Children: A Systematic Review and Meta-Analysis, Govaresh (2024)
3. Conventional and Molecular Investigation of Shigella Isolates in Relation to an Outbreak in the Area of Isfahan, Iran, Iranian Journal of Microbiology (2013)
4. Epidemiological Features of Irritable Bowel Syndrome and Its Subtypes Among Iranian Adults, Annals of Gastroenterology (2015)
5. Widespread Antibiotic Resistance of Diarrheagenic Escherichia Coli and Shigella Species, Journal of Research in Medical Sciences (2014)
6. Resistance of Shigella Strains to Extended-Spectrum Cephalosporins in Isfahan Province, Medical Journal of the Islamic Republic of Iran (2016)
7. Is Microscopic Colitis a Missed Diagnosis in Diarrhea-Predominant Irritable Bowel Syndrome?, Journal of Research in Medical Sciences (2008)
8. Metabolic Biomarkers in Irritable Bowel Syndrome Diagnosis, Clinica Chimica Acta (2024)
Experts (# of related papers)
View all Related Experts
Peyman Adibi (14)
Hamed Daghaghzadeh (5)
Other Related Docs
9. Prevalence and Antibiotic Resistance Profile of Shiga Toxin-Producing Escherichia Coli Isolated From Diarrheal Samples, Iranian Journal of Microbiology (2020)
10. Virulence Genes and Pulsed-Field Gel Electrophoresis Profiles of Shiga Toxin-Producing Escherichia Coli Isolated From Different Food Samples and Patients With Acute Diarrhea, Iranian Journal of Microbiology (2024)
11. Dietary Intake of Phytochemicals in Association With Irritable Bowel Syndrome in Adults, Clinical Nutrition ESPEN (2023)
12. The Effectiveness of Synbiotics in Preventing Antibiotic-Associated Diarrhea in Children: A Double-Blind Randomized Clinical Trial, Archives of Pediatric Infectious Diseases (2019)
13. Clinical Phenotype and Disease Course of Inflammatory Bowel Disease in Iran: Results of the Iranian Registry of Crohn's and Colitis (Ircc), Archives of Iranian Medicine (2024)
14. The Increasing Antimicrobial Resistance of Shigella Species Among Iranian Pediatrics: A Systematic Review and Meta-Analysis, Pathogens and Global Health (2023)
15. Inflammatory Bowel Disease Registry and Monitoring: Feasibility Study and Application (Isfahan Inflammatory Bowel Disease Surveillance Project), International Journal of Preventive Medicine (2019)
16. Oral Manifestations in Inflammatory Bowel Disease: A Cross-Sectional Study in Isfahan, Dental Research Journal (2021)
17. Sex-Related Differences in Clinical Symptoms, Quality of Life, and Biochemical Factors in Irritable Bowel Syndrome, Digestive Diseases and Sciences (2017)
18. Frequency and Risk Factors for Post-Covid-19 Functional Gastrointestinal Disorders After One Year, Shiraz E Medical Journal (2024)
19. Irritable Bowel Syndrome in Iran: Sepahan Systematic Review No. 1, International Journal of Preventive Medicine (2012)
20. The Prevalence of Adherent-Invasive Escherichia Coli and Its Association With Inflammatory Bowel Diseases: A Systematic Review and Meta-Analysis, Frontiers in Medicine (2021)
21. Prevalence of Intestinal Protozoan Infection in Patients With Ulcerative Colitis (Uc) in Isfahan, Iran, International Journal of Preventive Medicine (2021)
22. The Association Between Meal and Snack Frequency and Irritable Bowel Syndrome, Public Health Nutrition (2021)
23. Emerging Epidemic of Inflammatory Bowel Disease in a Middle Income Country: A Nation-Wide Study From Iran, Archives of Iranian Medicine (2016)
24. Face-To-Face Interviews Versus Internet Surveys: Comparison of Two Data Collection Methods in the Rome Foundation Global Epidemiology Study: Implications for Population-Based Research, Neurogastroenterology and Motility (2023)
25. Antibiotic Susceptibility Patterns of Isolates From Children With Urinary Tract Infection in Isfahan, Iran: Impact on Empirical Treatment, Journal of Global Antimicrobial Resistance (2017)
26. Food Item Avoidance of Patients With Irritable Bowel Syndrome Compared With Healthy People, Archives of Iranian Medicine (2019)
27. The Severity of Symptoms After Preparation for Colonoscopy in Irritable Bowel Syndromes; [شدت علایم در بیماران مبتلا به سندرم روده ی تحریک پذیر پس از آماده سازی برای کولونوسکپی], Journal of Isfahan Medical School (2023)
28. Iranian Registry of Crohn’S and Colitis: Study Profile of First Nation-Wide Inflammatory Bowel Disease Registry in Middle East, Intestinal Research (2019)
29. The Efficacy of a Synbiotic Containing Bacillus Coagulans in Treatment of Irritable Bowel Syndrome: A Randomized Placebo-Controlled Trial, Gastroenterology and Hepatology from Bed to Bench (2014)
30. The Assessment of the Correlation Between Sleep Quality and Irritable Bowel Syndrome Among Medical Students, Immunopathologia Persa (2022)
31. Associations of Antibiotics, Hormonal Therapies, Oral Contraceptives, and Long-Term Nsaids With Inflammatory Bowel Disease: Results From the Prospective Urban Rural Epidemiology (Pure) Study, Clinical Gastroenterology and Hepatology (2023)